Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZL-82 in moderate to severe atopic dermatitis
NCT07193589Phase 2Recruiting
- Sponsor
- Zenitar
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZL-82 in atopic dermatitis (AD), sponsored by Zenitar. Started Feb 2026; status: recruiting.
02
Drugs
ZL-82
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07193589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07193589.